Promethazine use among chronic pain patients

Drug and Alcohol Dependence

Volumn 150, Issue , 2015, Pages 92-97

  Lynch, Kara L ^a   Shapiro, Brad J ^a,b   Coffa, Diana ^a   Novak, Scott P ^c   Kral, Alex H ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

Chronic pain; Opioids; Pain management; Prescription drug abuse; Promethazine

Indexed keywords

HYDROCODONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE; PROMETHAZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; NARCOTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC PAIN; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHADONE TREATMENT; MORBIDITY; OPIATE ADDICTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; URINALYSIS; DRUG MISUSE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; CHRONIC PAIN; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; PROMETHAZINE; YOUNG ADULT;

EID: 84926409016     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.02.023     Document Type: Article

References (35)

1. Substance Abuse and Mental Health Services Administration Results from the 2012 Survey on Drug Use and Health: Summary of National Findings 2013, Substance Abuse and Mental Health Services Administration, Rockville, MD.
2. Adams L.L., Gatchel R.J., Robinson R.C., Polatin P., Gajraj N., Deschner M., Noe C. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J. Pain Sympt. Manag. 2004, 27:440-459.
3. Agnich L.E., Stogner J.M., Miller B.L., Marcum C.D. Purple drank prevalence and characteristics of misusers of codeine cough syrup mixtures. Addict. Behav. 2013, 38:2445-2449.
4. Banta-Green C.J., Jackson T.R., Hanrahan M., Nyrop K., Freng S., Kingston S., Forbes A., Albert D., Wrede A.F., Harruff R., Hewett G. Recent drug abuse trends in the Seattle-King County area, June 2004. Epidemiologic Trends in Drug Abuse Proceedings of the Community Epidemiology Work Group. NIH Publication No. 05-5282 2005, 249-277. National Institute on Drug Abuse, Division of Epidemiology, Services and Prevention Research.
5. Clatts M., Giang le M., Goldsamt L., Colon-Lopez V. Nonmedical use of promethazine hydrochloride among heroin injectors in Vietnam: unrecognized risks and unintended consequences. Subst. Use Misuse 2010, 45:515-527.
6. Compton W.M., Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006, 81:103-107.
7. Dunn K.M., Saunders K.W., Rutter C.M., Banta-Green C.J., Merrill J.O., Sullivan M.D., Weisner C.M., Silverberg M.J., Campbell C.I., Psaty B.M., Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann. Intern. Med. 2010, 152:85-92.
8. Elwood W.N. Sticky business: patterns of procurement and misuse of prescription cough syrup in Houston. J. Psychoact. Drugs 2001, 33:121-133.
9. Gerostamoulos J., Burke M.P., Drummer O.H. Involvement of codeine in drug-related deaths. Am. J. Forensic Med. Pathol. 1996, 17:327-335.
10. Hall A.J., Logan J.E., Toblin R.L., Kaplan J.A., Kraner J.C., Bixler D., Crosby A.E., Paulozzi L.J. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008, 300:2613-2620.
11. Jo S.H., Hong H.K., Chong S.H., Lee H.S., Choe H. H(1) antihistamine drug promethazine directly blocks hERG K(+) channel. Pharmacol. Res. 2009, 60:429-437.
12. Katz N.P., Sherburne S., Beach M., Rose R.J., Vielguth J., Bradley J., Fanciullo G.J. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth. Analg. 2003, 97:1097-1102.
13. Khosla N., Juon H.S., Kirk G.D., Astemborski J., Mehta S.H. Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. Addict. Behav. 2011, 36:1282-1287.
14. Lam L.C., Lee D.T., Shum P.P., Chen C.N. Cough mixture misuse in Hong Kong - an emerging psychiatric problem?. Addiction 1996, 91:1375-1378.
15. Manchikanti L., Cash K.A., Damron K.S., Manchukonda R., Pampati V., McManus C.D. Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables. Pain Physician 2006, 9:215-225.
16. Manchikanti L., Manchukonda R., Pampati V., Damron K.S. Evaluation of abuse of prescription and illicit drugs in chronic pain patients receiving short-acting (hydrocodone) or long-acting (methadone) opioids. Pain Physician 2005, 8:257-261.
17. Martell B.A., O'Connor P.G., Kerns R.D., Becker W.C., Morales K.H., Kosten T.R., Fiellin D.A. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann. Intern. Med. 2007, 146:116-127.
18. Mattoo S.K., Basu D., Balaji M., Sharma A., Malhotra A. Subtypes of codeine cough syrup abusers. Indian J. Med. Sci. 1999, 53:97-102.
19. Mattoo S.K., Basu D., Sharma A., Balaji M., Malhotra A. Abuse of codeine-containing cough syrups: a report from India. Addiction 1997, 92:1783-1787.
20. McGee J.P., Weiss W.A. Promethazine, an adjunct to preoperative medication. Ann. Surg. 1956, 144:861-864.
21. McLellan A.T., Turner B.J. Chronic noncancer pain management and opioid overdose: time to change prescribing practices. Ann. Intern. Med. 2010, 152:123-124.
22. Michna E., Jamison R.N., Pham L.D., Ross E.L., Janfaza D., Nedeljkovic S.S., Narang S., Palombi D., Wasan A.D. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin. J. Pain 2007, 23:173-179.
23. Ojha S.P., Sigdel S., Meyer-Thompson H.G., Oechsler H., Verthein U. 'South Asian cocktail' - the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour. Harm Reduct. J. 2014, 11. 17-7517-11-17.
24. Owczuk R., Twardowski P., Dylczyk-Sommer A., Wujtewicz M.A., Sawicka W., Drogoszewska B., Wujtewicz M. Influence of promethazine on cardiac repolarisation: a double-blind, midazolam-controlled study. Anaesthesia 2009, 64:609-614.
25. Page C.B., Duffull S.B., Whyte I.M., Isbister G.K. Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal. QJM 2009, 102:123-131.
26. Peters R., Yacoubian G.S., Rhodes W., Forsythe K.J., Bowers K.S., Eulian V.M., Mangum C.A., O'Neal J.D., Martin Q., Essien E.J. Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) use and addiction among multi-ethnic college students. J. Psychoact. Drugs 2007, 39:277-282.
27. Peters R.J., Kelder S.H., Markham C.M., Yacoubian G.S., Peters L.A., Ellis A. Beliefs and social norms about codeine and promethazine hydrochloride cough syrup (CPHCS) onset and perceived addiction among urban Houstonian adolescents: an addiction trend in the city of lean. J. Drug Educ. 2003, 33:415-425.
28. Richter P.A., Burk M.P. The potentiation of narcotic analgesics with phenothiazines. J. Foot Surg. 1992, 31:378-380.
29. Shapiro B.J., Lynch K.L., Toochinda T., Lutnick A., Cheng H.Y., Kral A.H. Promethazine misuse among methadone maintenance patients and community-based injection drug users. J. Addict. Med. 2013, 7:96-101.
30. Sharma A., Hamelin B.A. Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird's eye view. Curr. Drug Metab. 2003, 4:105-129.
31. Sharma Y., Mattoo S.K. Buprenorphine abuse in India: an update. Indian J. Psychiatry 1999, 41:154-159.
32. Shek D.T., Lam C.M. Adolescent cough medicine abuse in Hong Kong: implications for the design of positive youth development programs in Hong Kong. Int. J. Adolesc. Med. Health 2006, 18:493-503.
33. Shields L.B., Hunsaker J.C., Corey T.S., Ward M.K., Stewart D. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J. Forensic Sci. 2007, 52:1389-1395.
34. Singh R.A., Mattoo S.K., Malhotra A., Varma V.K. Cases of buprenorphine abuse in India. Acta Psychiatr. Scand. 1992, 86:46-48.
35. Wairagkar N.S., Das J., Kumar S., Mahanta J., Satyanarayana K., Phukan R.K., Chetia M., Goswami S.K. Codeine containing cough syrup addiction in Assam and Nagaland. Indian J. Psychiatry 1994, 36:129-132.